Erratum to: Proangiogenic TIE2+/CD31+ Macrophages Are the Predominant Population of Tumor-Associated Macrophages Infiltrating Metastatic Lymph Nodes (Molecules and Cells (2013) 36(5) (432–438), (S1016847823051749), (10.1007/s10059-013-0194-7));Proangiogenic TIE2+/CD31+ macrophages are the predominant population of tumor-associated macrophages infiltrating metastatic lymph nodes

Molecules and Cells

Volumn 36, Issue 5, 2013, Pages 432-438

  Kim, Ok Hee ^a   Kang, Gun Hyung ^a   Noh, Hyungjoon ^a   Cha, Ji Young ^a   Lee, Ho Jae ^a   Yoon, Jeong Hwan ^b   Mamura, Mizuko ^b   Nam, Jeong Seok ^a   Lee, Dae Ho ^c   Kim, Young A ^d   Park, Young Joo ^d   Kim, Hyeonjin ^d   Oh, Byung Chul ^a  

^a Gachon University College of Medicine   (South Korea)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Wonkwang University School of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Breast cancer; Melanoma; Metastasis; Proangiogenic macrophages; Tumor associated macrophages

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER THERAPY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD31; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, TIE-2; TUMOR MICROENVIRONMENT;

EID: 84900409193     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.1194     Document Type: Erratum

References (32)

1. Ahn, G.O., Tseng, D., Liao, C.H., Dorie, M.J., Czechowicz, A., and Brown, J.M. (2010). Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc. Natl. Acad. Sci. USA 107, 8363-8368.
2. Fei, Y.Y., Landry, J.P., Sun, Y.S., Zhu, X.D., Luo, J.T., Wang, X.B., and Lam, K.S. (2008). A novel high-throughput scanning microscope for label-free detection of protein and small-molecule chemical microarrays. Rev. Sci. Instrum. 79, 013708.
3. Garcia, J., Sandi, M.J., Cordelier, P., Binetruy, B., Pouyssegur, J., Iovanna, J.L., and Tournaire, R. (2012). Tie1 deficiency induces endothelial-mesenchymal transition. EMBO Rep. 13, 431-439.
4. Giatromanolaki, A., Koukourakis, M.I., Kakolyris, S., Kaklamanis, L., Barbatis, K., O'Byrne, K.J., Theodosssiou, D., Harris, A.L., and Gatter, K.C. (1998). Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer. Anticancer Res. 18, 71-76. (Pubitemid 28174687)
5. Groblewska, M., Mroczko, B., Wereszczynska-Siemiatkowska, U., Mysliwiec, P., Kedra, B., and Szmitkowski, M. (2007). Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin. Chem. Lab. Med. 45, 30-34. (Pubitemid 46155556)
6. Heusinkveld, M., and van der Burg, S.H. (2011). Identification and manipulation of tumor associated macrophages in human cancers. J. Transl. Med. 9, 216.
7. Hill, R.P., Chambers, A.F., Ling, V., and Harris, J.F. (1984). Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 224, 998-1001. (Pubitemid 14105763)
8. Huang, S., Xie, K., Bucana, C.D., Ullrich, S.E., and Bar-Eli, M. (1996). Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res. 2, 1969-1979. (Pubitemid 27006629)
9. Jenkins, S.J., Ruckerl, D., Cook, P.C., Jones, L.H., Finkelman, F.D., van Rooijen, N., MacDonald, A.S., and Allen, J.E. (2011). Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284-1288.
10. Kim, D.W., Min, H.S., Lee, K.H., Kim, Y.J., Oh, D.Y., Jeon, Y.K., Lee, S.H., Im, S.A., Chung, D.H., Kim, Y.T., et al. (2008). High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br. J. Cancer 98, 1118-1124. (Pubitemid 351399802)
11. Kim, S.J., Kim, J.S., Papadopoulos, J., Wook Kim, S., Maya, M., Zhang, F., He, J., Fan, D., Langley, R., and Fidler, I.J. (2009). Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am. J. Pathol. 174, 1972-1980.
12. Lan, C., Huang, X., Lin, S., Huang, H., Cai, Q., Wan, T., Lu, J., and Liu, J. (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol. Cancer Res. Treat 12, 259-267.
13. Mantovani, A., and Sica, A. (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237.
14. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555. (Pubitemid 35223554)
15. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
16. Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L.S., Gentner, B., Brown, J.L., Naldini, L., et al. (2011). Tar-geting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19, 512-526.
17. McKenney, J.K., Weiss, S.W., and Folpe, A.L. (2001). CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am. J. Surg. Pathol. 25, 1167-1173. (Pubitemid 32777716)
18. Pollard, J.W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
19. Pollard, J.W. (2008). Macrophages define the invasive micro-environment in breast cancer. J. Leukoc. Biol. 84, 623-630.
20. Pollard, J.W. (2009). Trophic macrophages in development and disease. Nat. Rev. Immunol. 9, 259-270.
21. Pucci, F., Venneri, M.A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., and De Palma, M. (2009) A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901-914.
22. Qian, B.Z., and Pollard, J.W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
23. Quatromoni, J.G., and Eruslanov, E. (2012). Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am. J. Transl. Res. 4, 376-389.
24. Ryder, M., Ghossein, R.A., Ricarte-Filho, J.C., Knauf, J.A., and Fagin, J.A. (2008). Increased density of tumor-associated macro-phages is associated with decreased survival in advanced thyroid cancer. Endocr. Relat. Cancer 15, 1069-1074.
25. Schoppmann, S.F., Fenzl, A., Nagy, K., Unger, S., Bayer, G., Geleff, S., Gnant, M., Horvat, R., Jakesz, R., and Birner, P. (2006). VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139, 839-846. (Pubitemid 43902914)
26. Steidl, C., Lee, T., Shah, S.P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S.J., Iqbal, J., Weisenburger, D.D., et al. (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 362, 875-885.
27. Welford, A.F., Biziato, D., Coffelt, S.B., Nucera, S., Fisher, M., Pucci, F., Di Serio, C., Naldini, L., De Palma, M., Tozer, G.M., et al. (2011). TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J. Clin. Invest. 121, 1969-1973.
28. White, E.S., Flaherty, K.R., Carskadon, S., Brant, A., Iannettoni, M.D., Yee, J., Orringer, M.B., and Arenberg, D.A. (2003). Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin. Cancer Res. 9, 853-860. (Pubitemid 36182624)
29. Xu, J., Escamilla, J., Mok, S., David, J., Priceman, S., West, B., Bollag, G., McBride, W., and Wu, L. (2013). CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res. 73, 2782-2794.
30. Yang, H., Kim, C., Kim, M.J., Schwendener, R.A., Alitalo, K., Heston, W., Kim, I., Kim, W.J., and Koh, G.Y. (2011). Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol. Cancer 10, 36.
31. Zeisberger, S.M., Odermatt, B., Marty, C., Zehnder-Fjallman, A.H., Ballmer-Hofer, K., and Schwendener, R.A. (2006). Clodronate-liposome- mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95, 272-281. (Pubitemid 44187587)
32. Zijlmans, H.J., Fleuren, G.J., Baelde, H.J., Eilers, P.H., Kenter, G.G., and Gorter, A. (2006). The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2. J. Pathol. 208, 507-517. (Pubitemid 43329337)